Beijing Konruns Pharmaceutical Co (SHSE:603590) Accounts Receivable

: ¥295.0 Mil (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Beijing Konruns Pharmaceutical Co's accounts receivables for the quarter that ended in Sep. 2023 was ¥295.0 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Beijing Konruns Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Sep. 2023 was 100.00.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Beijing Konruns Pharmaceutical Co's Net-Net Working Capital per share for the quarter that ended in Sep. 2023 was ¥1.35.

Beijing Konruns Pharmaceutical Co Accounts Receivable Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Accounts Receivable

Get a 7-Day Free Trial

221.42

216.09

174.70

233.99

276.72

Beijing Konruns Pharmaceutical Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Accounts Receivable	Get a 7-Day Free Trial															212.81	276.72	258.15	307.79	295.01

Beijing Konruns Pharmaceutical Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Beijing Konruns Pharmaceutical Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Beijing Konruns Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	295.008	/	269.201	*	91
=	100.00

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Beijing Konruns Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Beijing Konruns Pharmaceutical Co's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2023 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(616.122	+	0.75 * 295.008	+	0.5 * 44.485	-	363.472
-	0	-	279.522)	/	160
=	1.35

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Beijing Konruns Pharmaceutical Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN

Website

http://www.konruns.cn

Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Headlines

No Headlines